Results 1 to 10 of about 37,679 (252)

Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies [PDF]

open access: yesSaudi Pharmaceutical Journal, 2018
Objectives: Pregabalin is currently approved for the treatment of epilepsy, generalized anxiety disorder, neuropathic pain and fibromyalgia. Rising attention to the abuse liability of pregabalin causing addictive behaviors is partially based on case ...
Amneh Al-Husseini   +3 more
doaj   +3 more sources

Pregabalin acts on Na+–Ca2+ exchanger, which promotes Ca2+ extrusion from human Merkel cell line [PDF]

open access: yesPAIN Reports
. Introduction:. Pregabalin, a first-line treatment for neuropathic pain, binds to the voltage-gated calcium channel auxiliary subunit alpha2delta-1, reducing neurotransmitter release.
Rumi Kaneko   +5 more
doaj   +2 more sources

Patterns of pregabalin prescribing in four German federal states: analysis of routine data to investigate potential misuse of pregabalin

open access: yesBMJ Open, 2022
Objectives The objectives of this study were to investigate the utilisation patterns of pregabalin, to identify users potentially misusing pregabalin and to compare this group of patients to patients prescribed recommended doses of pregabalin concerning ...
Ronja Flemming
doaj   +1 more source

Pregabalin abuse: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Pregabalin is a gamma-amino butyric acid (GABA) analogue used in the treatment of epilepsy, neuropathic pain, and generalized anxiety disorder. Although pregabalin is not a controlled medication in Turkey, it has a potential risk of abuse.
Ilhan Yargic, Filiz Alyanak Ozdemiroglu
doaj   +1 more source

Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review

open access: yesNeuropsychopharmacology Reports, 2021
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or abuse, and little attention has been paid to patients who are prescribed
Hayahito Ishikawa   +5 more
doaj   +1 more source

The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study

open access: yesSaudi Pharmaceutical Journal, 2023
Background: The Saudi Food and Drug Authority (SFDA) classified pregabalin as a controlled substance in 2018; however, whether this policy change has affected pregabalin use is unclear.
Ahmed Al-jedai   +6 more
doaj   +1 more source

PREGABALIN EFFECTS ON CELLULAR AND HUMORAL COMPONENTS OF BLOOD OF MICE (Mus musculus) [PDF]

open access: yesBasrah Journal of Veterinary Research, 2017
The oral use of pregabalin was evaluated in this study to reveal its effects on some hematological and biochemical parameters of laboratory mice. The animals of this study were divided into three groups (twelve mice each).
Wissam Sajid Hashim Al-Uboody
doaj   +1 more source

Pregabalin addiction caracteristics at oran: A cohort study

open access: yesEuropean Psychiatry, 2021
Introduction Pregabalin is an analogue of gamma-aminobutyric acid (GABA). Recent reports suggest illicit pregabalin use may be increasing among youth, however its addictive potential has not been well established (1). Objectives Drug seeking behavior
C. Yasmine, D. Aicha
doaj   +1 more source

9-PREGABALIN EFFECTS ON CELLULAR AND HUMORAL COMPONENTS OF BLOOD OF MICE (Mus musculus) [PDF]

open access: yesBasrah Journal of Veterinary Research, 2018
The oral use of pregabalin was evaluated in this study to reveal its effects on some hematological and biochemical parameters of laboratory mice. The animals of this study were divided into three groups (twelve mice each).
Wissam Sajid Hashim Al-Uboody
doaj   +1 more source

Fixed dose combination of low dose pregabalin and duloxetine, or pregabalin monotherapy for neuropathic pain: A double-blind, randomized, parallel-group study [version 1; peer review: 2 approved]

open access: yesF1000Research, 2023
Background: Treatment of neuropathic pain is challenging. Pregabalin and duloxetine are used as first-line therapy. Various international guidelines recommend a combination of first-line agents for the management of neuropathic pain.
Sunil Dutt   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy